• Je něco špatně v tomto záznamu ?

Beneficial effects of Stevioside on AGEs, blood glucose, lipid profile and renal status in streptozotocin-induced diabetic rats

Umila Aswar, Vinayak Gogawale, Pankaj Miniyar, Yugendra Patil

. 2019 ; 17 (3) : 191-197.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19039391

The advanced glycated end products (AGEs) are formed in the diabetic patients; it is a major cause of macrovascular and microvascular complications in diabetes. Clinically there is no treatment available for the AGEs. Stveoside (Stv), a sweetener has potent anti-diabetic and anti-oxidant activity. Hence, we investigated its use in prevention of AGEs formation using in vitro and in vivo models. Diabetes was induced by streptozotocin (STZ). These rats were kept without treatment till blood HbA1c was markedly increased. They were then divided into 5 groups and treated orally with vehicle or Metformin (MET) or Stv respectively for 28 days. Every 7th day, animals were tested for body weight and blood glucose (BG). On the last day of treatment, all the groups were evaluated for physiological and biochemical parameters, histopathology and AGEs; N-carboxymethyl-lysine (CML) estimation. Stv showed inhibition of AGEs in in vitro as well as in in vivo respectively. Positive effects were seen on the BG, lipid profile and urine parameters as well it showed reduced formation of CML. It also showed antihyperglycaemic, antihyperlipedemic and nephroprotective activities. The present study provides scientific rationale for the use of Stv as a sweetener with additional benefits in diabetes.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19039391
003      
CZ-PrNML
005      
20200829155504.0
007      
ta
008      
191108s2019 xr da f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2019.013 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Aswar, Umila $u Bharati Vidyapeeth (Deemed to be University), Poona College of Pharmacy, Erandwane, Pune, Maharashtra, India
245    10
$a Beneficial effects of Stevioside on AGEs, blood glucose, lipid profile and renal status in streptozotocin-induced diabetic rats / $c Umila Aswar, Vinayak Gogawale, Pankaj Miniyar, Yugendra Patil
504    __
$a Literatura
520    9_
$a The advanced glycated end products (AGEs) are formed in the diabetic patients; it is a major cause of macrovascular and microvascular complications in diabetes. Clinically there is no treatment available for the AGEs. Stveoside (Stv), a sweetener has potent anti-diabetic and anti-oxidant activity. Hence, we investigated its use in prevention of AGEs formation using in vitro and in vivo models. Diabetes was induced by streptozotocin (STZ). These rats were kept without treatment till blood HbA1c was markedly increased. They were then divided into 5 groups and treated orally with vehicle or Metformin (MET) or Stv respectively for 28 days. Every 7th day, animals were tested for body weight and blood glucose (BG). On the last day of treatment, all the groups were evaluated for physiological and biochemical parameters, histopathology and AGEs; N-carboxymethyl-lysine (CML) estimation. Stv showed inhibition of AGEs in in vitro as well as in in vivo respectively. Positive effects were seen on the BG, lipid profile and urine parameters as well it showed reduced formation of CML. It also showed antihyperglycaemic, antihyperlipedemic and nephroprotective activities. The present study provides scientific rationale for the use of Stv as a sweetener with additional benefits in diabetes.
650    _2
$a lidé $7 D006801
650    12
$a Stevia $7 D036625
650    _2
$a sladidla $x terapeutické užití $7 D013549
650    _2
$a fytoterapie $7 D008517
650    _2
$a glykosidy $x terapeutické užití $7 D006027
650    12
$a produkty pokročilé glykace $7 D017127
650    12
$a glykosylace $x účinky léků $7 D006031
650    12
$a komplikace diabetu $x terapie $7 D048909
650    12
$a diabetes mellitus $x prevence a kontrola $x terapie $7 D003920
650    _2
$a techniky in vitro $7 D066298
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a krevní glukóza $x účinky léků $7 D001786
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a renální insuficience $x prevence a kontrola $7 D051437
650    _2
$a lipidy $7 D008055
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gogawale, Vinayak $u STES's Sinhgad Institute of Pharmacy, Savitribai Phule Pune University, Narhe, Pune, Maharashtra, India
700    1_
$a Miniyar, Pankaj $u STES's Sinhgad Institute of Pharmacy, Savitribai Phule Pune University, Narhe, Pune, Maharashtra, India
700    1_
$a Patil, Yugendra $u National Chemical Laboratory, Pune, Maharashtra, India
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 17, č. 3 (2019), s. 191-197 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2019/03/06.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20191108081817 $b ABA008
991    __
$a 20200829155506 $b ABA008
999    __
$a ok $b bmc $g 1462739 $s 1077980
BAS    __
$a 3
BMC    __
$a 2019 $b 17 $c 3 $d 191-197 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK183 $d 20200829 $a NLK 2019-51/vt

Najít záznam

Citační ukazatele

Možnosti archivace